Platelet-Rich Plasma, Bone Morphogenetic Protein, and Stem Cell Therapies

Area of Science:

• Orthopaedic Surgery
• Regenerative Medicine
• Biologics in Medicine

Background:

• Biologic therapies, including platelet-rich plasma (PRP), bone morphogenetic protein (BMP), and stem cells, have seen a significant rise in orthopaedic applications.
• These treatments are explored for diverse conditions such as osteoarthritis, tendon and muscle injuries, and soft-tissue damage.
• Biologics are also investigated for their potential to enhance healing in surgical procedures.

Purpose of the Study:

• To review the current literature on the use and efficacy of biologics in orthopaedic treatment.
• To summarize the applications of PRP, BMP, and stem cells in managing musculoskeletal conditions.
• To assess the evidence supporting biologic therapies in orthopaedic surgery and injury recovery.

Main Methods:

• Literature review of scientific publications on biologic therapies in orthopaedics.
• Analysis of studies investigating platelet-rich plasma (PRP), bone morphogenetic protein (BMP), and stem cell therapies.
• Synthesis of evidence regarding the application of these biologics for various orthopaedic conditions and surgical enhancements.

Main Results:

• The use of PRP and stem cells is proposed for osteoarthritis, tendon injuries, muscle strains, and soft-tissue injuries.
• BMP has demonstrated utility in promoting fracture union and spinal fusion.
• Biologics are being researched as adjuncts in various surgical procedures to improve healing outcomes.

Conclusions:

• The application of biologics in orthopaedics is expanding, with growing research interest.
• Evidence supports the use of PRP, BMP, and stem cells for a range of orthopaedic conditions.
• Further research is ongoing to fully elucidate the role and effectiveness of these regenerative therapies.